Placental Pathology Contributes to Impaired Volumetric Brain Development in Neonates With Congenital Heart Disease
- PMID: 38420785
- PMCID: PMC10944035
- DOI: 10.1161/JAHA.123.033189
Placental Pathology Contributes to Impaired Volumetric Brain Development in Neonates With Congenital Heart Disease
Abstract
Background: Neonates with congenital heart disease are at risk for impaired brain development in utero, predisposing children to postnatal brain injury and adverse long-term neurodevelopmental outcomes. Given the vital role of the placenta in fetal growth, we assessed the incidence of placental pathology in fetal congenital heart disease and explored its association with total and regional brain volumes, gyrification, and brain injury after birth.
Methods and results: Placentas from 96 term singleton pregnancies with severe fetal congenital heart disease were prospectively analyzed for macroscopic and microscopic pathology. We applied a placental pathology severity score to relate placental abnormalities to neurological outcome. Postnatal, presurgical magnetic resonance imaging was used to analyze brain volumes, gyrification, and brain injuries. Placental analyses revealed the following abnormalities: maternal vascular malperfusion lesions in 46%, nucleated red blood cells in 37%, chronic inflammatory lesions in 35%, delayed maturation in 30%, and placental weight below the 10th percentile in 28%. Severity of placental pathology was negatively correlated with cortical gray matter, deep gray matter, brainstem, cerebellar, and total brain volumes (r=-0.25 to -0.31, all P<0.05). When correcting for postmenstrual age at magnetic resonance imaging in linear regression, this association remained significant for cortical gray matter, cerebellar, and total brain volume (adjusted R2=0.25-0.47, all P<0.05).
Conclusions: Placental pathology occurs frequently in neonates with severe congenital heart disease and may contribute to impaired brain development, indicated by the association between placental pathology severity and reductions in postnatal cortical, cerebellar, and total brain volumes.
Keywords: brain development; congenital heart disease; fetus; magnetic resonance imaging; neonate; neuroplacentology; placenta.
Figures


Comment in
-
Placenta-Heart-Brain Connection in Congenital Heart Disease.J Am Heart Assoc. 2024 Mar 5;13(5):e033875. doi: 10.1161/JAHA.124.033875. Epub 2024 Feb 29. J Am Heart Assoc. 2024. PMID: 38420776 Free PMC article. No abstract available.
Similar articles
-
Placental delayed villous maturation is associated with fetal congenital heart disease.Am J Obstet Gynecol. 2023 Feb;228(2):231.e1-231.e11. doi: 10.1016/j.ajog.2022.08.013. Epub 2022 Aug 17. Am J Obstet Gynecol. 2023. PMID: 35985515 Free PMC article.
-
Placental vascular malperfusion lesions in fetal congenital heart disease.Am J Obstet Gynecol. 2022 Oct;227(4):620.e1-620.e8. doi: 10.1016/j.ajog.2022.05.038. Epub 2022 May 21. Am J Obstet Gynecol. 2022. PMID: 35609643
-
Brain and CSF Volumes in Fetuses and Neonates with Antenatal Diagnosis of Critical Congenital Heart Disease: A Longitudinal MRI Study.AJNR Am J Neuroradiol. 2019 May;40(5):885-891. doi: 10.3174/ajnr.A6021. Epub 2019 Mar 28. AJNR Am J Neuroradiol. 2019. PMID: 30923087 Free PMC article.
-
Neuroplacentology in congenital heart disease: placental connections to neurodevelopmental outcomes.Pediatr Res. 2022 Mar;91(4):787-794. doi: 10.1038/s41390-021-01521-7. Epub 2021 Apr 16. Pediatr Res. 2022. PMID: 33864014 Free PMC article. Review.
-
Placenta morphology and biomarkers in pregnancies with congenital heart disease - A systematic review.Placenta. 2021 Sep 1;112:189-196. doi: 10.1016/j.placenta.2021.07.297. Epub 2021 Aug 8. Placenta. 2021. PMID: 34388551
Cited by
-
Assessment of Neurodevelopmental Outcomes in Children With Congenital Heart Disease Using Magnetic Resonance Imaging (MRI): Focus on Brain Volume as a Predictor of Neurodevelopmental Abnormalities.J Multidiscip Healthc. 2025 Feb 27;18:1241-1248. doi: 10.2147/JMDH.S508533. eCollection 2025. J Multidiscip Healthc. 2025. PMID: 40035029 Free PMC article.
-
Placenta-Heart-Brain Connection in Congenital Heart Disease.J Am Heart Assoc. 2024 Mar 5;13(5):e033875. doi: 10.1161/JAHA.124.033875. Epub 2024 Feb 29. J Am Heart Assoc. 2024. PMID: 38420776 Free PMC article. No abstract available.
-
Cord blood levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 correlate with perinatal brain development in fetal congenital heart disease.Ultrasound Obstet Gynecol. 2025 Aug;66(2):200-209. doi: 10.1002/uog.29271. Epub 2025 Jun 28. Ultrasound Obstet Gynecol. 2025. PMID: 40580544 Free PMC article.
-
Placental Inflammation in Preterm Premature Rupture of Membranes and Risk of Neurodevelopmental Disorders.Cells. 2025 Jun 24;14(13):965. doi: 10.3390/cells14130965. Cells. 2025. PMID: 40643486 Free PMC article. Review.
-
DNA methylation differences stratified by normalized fetal/placental weight ratios suggest neurodevelopmental deficits in neonates with congenital heart disease.PLoS One. 2025 Aug 6;20(8):e0317944. doi: 10.1371/journal.pone.0317944. eCollection 2025. PLoS One. 2025. PMID: 40768515 Free PMC article.
References
-
- Bonthrone AF, Stegeman R, Feldmann M, Claessens NHP, Nijman M, Jansen NJG, Nijman J, Groenendaal F, de Vries LS, Benders MJNL, et al. Risk factors for perioperative brain lesions in infants with congenital heart disease: a European collaboration. Stroke. 2022;53:3652–3661. doi: 10.1161/STROKEAHA.122.039492 - DOI - PMC - PubMed
-
- Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, Grosse‐Wortmann L, Jaeggi E, McCrindle BW, Kingdom J, et al. Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Circulation. 2015;131:1313–1323. doi: 10.1161/CIRCULATIONAHA.114.013051 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical